Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Baseline Performance Predicts tDCS-mediated Improvements in Language Symptoms in Primary Progressive Aphasia

NCT02928848 is registered in ClinicalTrials.gov with University of Pennsylvania as lead sponsor.

NCT NCT02928848
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02928848 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Baseline Performance Predicts tDCS-mediated Improvements in Language Symptoms in Primary Progressive Aphasia
Lead sponsor
University of Pennsylvania
Phase
Not applicable
Overall status
Completed
Start date
June 16, 2017
Completion date
March 13, 2020
Enrollment
16 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

primary progressive aphasia